Tag: drug-coated balloons market demand

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Drug-Coated Balloons Market Expected To Expand Between 2025 And 2029?

The valuation of the drug-coated balloons sector has experienced swift escalation lately, projected to advance from a market worth 1.08 billion US dollars in 2024 to 1.24 billion US dollars in 2025, reflecting a compound annual growth rate approximating 14.6%. This expansion observed during the preceding period stems from several contributing factors, notably the rising incidence of cardiovascular ailments, a heightened need for less invasive surgical interventions, the widespread occurrence of peripheral artery disease (pad), successful efforts to lower rates of restenosis, and ongoing progress within the field of interventional cardiology.

Anticipation surrounds the drug-coated balloons sector, projecting substantial escalation in its valuation over the forthcoming years, reaching $2.2 billion by 2029, propelled by a compound annual growth rate (CAGR) of 15.5%. This considerable upswing anticipated during the projection timeframe is fundamentally driven by several factors, including the swelling demographic of elderly individuals, the broadening scope of available indications and applications, a strategic shift toward care delivery in outpatient settings and ambulatory centers, the incorporation of advancements in drug conveyance technologies, and various worldwide health campaigns. Key developments influencing this period are characterized by the securing of official clearances for novel product compositions, a concerted effort to reduce adverse effects, the advent of biodegradable surface treatments, market penetration into developing nations, and an increasing emphasis on methods tailored to individual patient needs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

Which Major Market Drivers Are Shaping The Future Of The Drug-Coated Balloons Market?

Anticipated escalation in the occurrence of coronary artery disease is set to drive the expansion of the drug-coated balloons market in the future. Coronary artery disease (CAD), characterized by the constriction or blockage of the arteries supplying blood to the cardiac muscle, frequently results in myocardial infarction events. Drug-coated balloons represent a specific medical apparatus deployed in managing CAD; during the interventional process, medication is delivered directly into the vessel to mitigate the recurrence of artery narrowing post-angioplasty, known as restenosis. Evidence supporting this trend emerged in August 2022, when a publication in the Journal of the American College of Cardiology, originating from a US entity, projected that all four primary cardiovascular risk factors would increase among the overall American populace between 2025 and 2060; diabetes is projected to see the most substantial surge at 39.3%, succeeded by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity recording an 18.3% rise. Furthermore, the investigators determined that the highest projected escalations in incidence rates belonged to heart failure (33.4%) and ischemic heart disease (30.7%), with heart attack (16.9%) and stroke (33.8%) also showing significant anticipated increases. Consequently, the growing incidence rate of coronary artery disease is projected to provide significant impetus to the market for drug-coated balloons.

What Are The Leading Segments Analyzed In The Drug-Coated Balloons Market?

The drug-coated balloonsmarket covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

What Key Innovation Trends Are Fueling Advancements In The Drug-Coated Balloons Market?

A prominent trend in the market for drug-coated balloons involves a significant push toward product advancements, with key players actively channeling resources into pioneering technological and inventive remedies to solidify their standing. As an illustration of this focus, in August of 2022, the American medical technology firm Becton, Dickinson, and Company (BD) initiated the PREVISION first-in-human investigation concerning a peripheral sirolimus drug-coated balloon (DCB); the primary goal of this clinical study is to evaluate both the safety profile and the efficacy of the sirolimus DCB when administered to individuals afflicted by peripheral artery disease, a serious ailment that substantially compromises patients’ ability to move and their overall standard of living.

Which Major Industry Participants Are Leading The Drug-Coated Balloons Market Growth?

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Which Geographies Are Emerging As Strong Markets For The Drug-Coated Balloons Industry?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Drug-Coated Balloons Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Browse Through More Reports Similar to the Global Drug-Coated Balloons Market 2025, By The Business Research Company

Pta Balloon Catheter Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

Antispasmodics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Drug-Coated Balloons Market Valuation Change Between Now And 2029?

In the past few years, the market size for drug-coated balloons has seen a fast-paced expansion. The market is projected to swell from $1.08 billion in 2024 to $1.24 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.6%. Factors contributing to the growth during the historic period include an uptick in cardiovascular illnesses, rising demand for less invasive surgical procedures, the widespread occurrence of peripheral artery malady (PAD), decreased restenosis rates, and advancements in the field of interventional cardiology.

In the years to come, the drug-coated balloons market size is projected to experience swift growth, reaching a value of $2.2 billion in 2029 with a compound annual growth rate (CAGR) of 15.5%. The expansion during the forecasted period can be associated with factors such as the growing aging population, broader indications and applications, emphasis on outpatient and ambulatory care, integration with drug delivery innovations, and global health initiatives. The forecast period will also see significant trends like regulatory approvals for novel formulations, efforts to reduce side effects, the rise of bioresorbable coatings, expansion of the market in emerging economies, and patient-oriented approaches.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What Growth-Enabling Forces Are Impacting The Drug-Coated Balloons Market?

The increase in coronary artery disease cases is predicted to fuel the expansion of the market for drug-coated balloons. Coronary artery disease (CAD) is a health issue characterized by the constriction or blockage of the coronary arteries, which supply blood to the heart muscle, resulting in heart attacks. A drug-coated balloon is a medical tool utilized in the treatment of coronary artery disease, with the drug being released into the artery during the procedure to avoid restenosis, the subsequent contraction of the artery post-angioplasty. For example, a study published in the Journal of the American College of Cardiology in August 2022 revealed that all four cardiovascular risk factors are projected to increase in the general U.S. population between 2025 and 2060. Diabetes is predicted to spike the most, by 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. The study also found that heart failure (33.4%) and ischemic heart disease (30.7%) are forecasted to witness the most significant escalation in rates, subsequently followed by heart attacks (16.9%) and strokes (33.8%). Consequently, the surge in coronary artery disease cases is anticipated to propel the drug-coated balloon market.

What Are The Main Segment Classifications In The Drug-Coated Balloons Market?

The drug-coated balloonsmarket covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

How Are Industry Trends Steering The Expansion Of The Drug-Coated Balloons Market?

One of the prominent trends in the drug-coated balloon market is product innovation. Many of the primary market players are investing in the development of technologically advanced and innovative solutions to secure their market standing. For example, Becton, Dickinson, and Company (BD), a medical technology company based in the US, in August 2022, launched the PREVISION trial, a pioneering venture involving a peripheral sirolimus drug-coated balloon (DCB). The objective of this trial is to evaluate the safety and potential benefits of the sirolimus DCB in the treatment of patients suffering from peripheral artery disease, a disorder that greatly affects patients’ mobility and life quality.

Which Firms Are Driving Innovation Within The Drug-Coated Balloons Market?

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

What Are The Emerging Regional Trends Driving The Drug-Coated Balloons Market?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Browse Through More Reports Similar to the Global Drug-Coated Balloons Market 2025, By The Business Research Company

Pta Balloon Catheter Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

Antispasmodics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Drug-Coated Balloons Market Expected to Grow Between 2025 And 2029?

In recent times, the size of the market for drug-coated balloons has seen significant growth. It is forecasted to expand from $1.08 billion in 2024 to $1.24 billion in 2025 with a compound annual growth rate (CAGR) of 14.6%. This growth over the historical period has been driven by a rise in cardiovascular disease cases, increased demand for less invasive procedures, a higher prevalence of peripheral artery disease (PAD), lower rates of restenosis, and advancements in the field of interventional cardiology.

The market size of drug-coated balloons is projected to witness a swift expansion in the coming years. An expected rise to $2.2 billion by 2029 is predicted, with a compound annual growth rate (CAGR) of 15.5%. This growth over the forecast period can be credited to factors such as a growing aging populace, broadening of indications and applications, a shift towards outpatient and ambulatory care, merging with advancements in drug delivery, and worldwide health initiatives. The forecast period will also see significant trends such as approval of new formulations from regulators, emphasis on reducing side effects, development of bioresorbable coatings, market growth in developing economies, and patient-centered strategies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What Are the Core Growth Drivers Propelling the Drug-Coated Balloons Market Forward?

The anticipated escalation in occurrences of coronary artery disease is presumed to drive the growth of the drug-coated balloons market. Coronary artery disease (CAD) is a medical term for the restriction or blockage of the coronary arteries that supply blood to the heart muscle, resulting in heart attacks. Drug-coated balloons are medical devices utilized in the treatment of this disease. The drug is administered into the artery during the procedure to minimize the chances of restenosis, a condition where the artery re-narrows after angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 suggested that all four cardiovascular risk factors, namely diabetes, dyslipidemia, hypertension, and obesity, are projected to rise in the U.S. between 2025 and 2060. The study showed that diabetes will surge by 39.3% followed by dyslipidemia at 27.6%, hypertension’s rise at 25.1%, and obesity’s increase at 18.3%. The research also found that heart failure and ischemic heart disease will potentially experience the greatest surges at 33.4% and 30.7% respectively. Heart attacks and stroke also have anticipated increases of 16.9% and 33.8% respectively. Therefore, this increase in instances of coronary artery disease is foreseen to catalyze the expansion of the drug-coated balloon market.

What Segment Types Define the Drug-Coated Balloons Market Structure?

The drug-coated balloonsmarket covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Drug-Coated Balloons Market?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Emerging Trends that Are Influencing theDrug-Coated Balloons Industry Evolution?

The rise in product innovations is a crucial trend observed in the drug-coated balloon market. Businesses in this market are concentrating on the creation of new technologies and inventive solutions as a means to consolidate their market presence. For instance, Becton, Dickinson, and Company (BD), a medical technology company based in the US, initiated the first human trial of the PREVISION peripheral sirolimus drug-coated balloon (DCB) in August 2022. This trial is being conducted to evaluate the safety and performance of the sirolimus DCB in managing patients with peripheral artery disease, a malady that drastically affects mobility and quality of living.

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

What Is the Definition of the Drug-Coated Balloons Market?

A drug-coated balloon (DCB) is a medical device used in the treatment of narrowed or blocked blood vessels, primarily in the field of interventional cardiology and interventional radiology. It is designed to deliver medication directly to the site of vascular disease while simultaneously performing angioplasty.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10829

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Drug-Coated Balloons Market Growth in 2025?

In recent times, the market size of drug-coated balloons has seen considerable expansion. The forecast suggests an upward trend from $1.08 billion in 2024 to $1.24 billion in 2025, indicating a compound annual growth rate (CAGR) of 15.4%. The significant growth observed in the past has been driven by factors such as a rising incidence of cardiovascular disease, the need for less invasive procedures, a higher prevalence of peripheral artery disease (pad), lowering rates of restenosis, and advancements in the field of interventional cardiology.

What Is the Forecast for the Drug-Coated Balloons Market Size Through 2029?

Expectations are high for the drug-coated balloons market to experience accelerated growth in the coming years, with projections pointing to a valuation of “$2.22 billion by 2029, and a compound annual growth rate (CAGR) of 15.6%. The substantial increase predicted within the forecast period can be linked to a thriving older population, the widening scope of indications and applications, an emphasis on outpatient and ambulatory care, the merging with innovative drug delivery solutions, and international health initiatives. Key trends anticipated during the forecast period involve receiving regulatory authorization for new mixtures, a focus on reducing adverse side effects, the rise of bioresorbable coatings, burgeoning markets within emerging economies, and a move towards patient-centric strategies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What are the Key Market Players in Drug-Coated Balloons Market and How They’re Evolving?

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

What Are the Primary Growth Drivers in the Drug-Coated Balloons Market?

The anticipated increase in incidents of coronary artery disease (CAD) is believed to drive the expansion of the drug-coated balloon market. CAD, a medical condition characterized by the narrowing or blockage of coronary arteries that supply blood to the heart muscle, can result in heart attacks. The drug-coated balloon is a therapeutic device employed in the treatment of CAD. The drug contained within the balloon is dispensed into the artery during the procedure to deter restenosis, or the re-narrowing of the artery post-angioplasty. For instance, a study published by a US-based organization in the Journal of the American College of Cardiology in August 2022 indicated that all four cardiovascular risk factors are predicted to increase in the general U.S. population from 2025 to 2060. Diabetes is projected to see the largest percentage increase of 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. The study found that heart failure (33.4%) and ischemic heart disease (30.7%) are the conditions with the largest projected increases, followed by heart attack (16.9%) and stroke (33.8%). Hence, the anticipated rise in CAD cases is projected to stimulate the growth of the drug-coated balloon market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

What Are the Leading Segments in the Global Drug-Coated Balloons Industry?

The drug-coated balloons market covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

What Are the Key Market Trends in the Drug-Coated Balloons Industry?

A prevalent trend in the drug-coated balloon market is product innovation. To solidify their standing in the market, dominant firms are concentrating on creating novel and cutting-edge solutions. As an example, Becton, Dickinson, and Company (BD), an American medical technology firm, initiated the PREVISION first-of-its-kind trial in August 2022 for a peripheral sirolimus drug-coated balloon (DCB). The goal of this trial is to evaluate the effectiveness and safety of the sirolimus DCB in treating those suffering from peripheral artery disease, a disorder that greatly affects movement and the standard of living.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

What Is the Regional Outlook for the Drug-Coated Balloons Market?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10829

This Report Delivers Insight On:

1. How big is the drug-coated balloons market, and how is it changing globally?

2. Who are the major companies in the drug-coated balloons market, and how are they performing?

3. What are the key opportunities and risks in the drug-coated balloons market right now?

4. Which products or customer segments are growing the most in the drug-coated balloons market?

5. What factors are helping or slowing down the growth of the drug-coated balloons market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the drug-coated balloons market size evolved in recent years?

The size of the drug-coated balloons market has seen swift expansion in the last few years. Projections indicate a growth from $1.08 billion in 2024 to $1.24 billion in 2025, maintaining a compound annual growth rate (CAGR) of 15.4%. The growth in this past period is due to factors such as the rising prevalence of cardiovascular disease, an increase in demand for less invasive procedures, widespread peripheral artery disease (PAD), a decrease in restenosis rates, and advancements in the field of interventional cardiology.

What are the predictions for the drug-coated balloons market size in the coming years?

The market size of drug-coated balloons is predicted to experience significant growth in the coming years. An expansion to “$2.22 billion by 2029” is anticipated, with a compound annual growth rate (CAGR) of 15.6%. Factors contributing to the growth during the projected period include a rising aging demographic, broadening of indications and applications, a focus on outpatient and ambulatory assistance, combination with drug delivery developments, and global health initiatives. Foreseen trends within this forecast period encompass regulatory endorsements for new mixes, an emphasis on reducing side effects, the introduction of bioresorbable coatings, market growth in budding economies, and patient-oriented strategies.

Get your drug-coated balloons market report here!

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

What key factors are fueling the growth of the drug-coated balloons market?

The increasing incidence of coronary artery disease is anticipated to drive the growth of the drug-coated balloons market. Defined as the narrowing or blockage of arteries that supply blood to the heart muscle, coronary artery disease (CAD) often leads to heart attacks. Drug-coated balloons are used in the medical treatment of this condition by releasing drugs into the artery during a procedure to avert restenosis, or the subsequent narrowing of the artery post-angioplasty. In August 2022, a study published in the Journal of the American College of Cardiology, a US-based organization, predicted an increase in all four cardiovascular risk factors within the U.S. population between 2025 and 2060. It projected diabetes to experience the greatest increase at 39.3%, followed by dyslipidemia (27.6%), hypertension (25.1%), and obesity (18.3%). The report also showed a projected higher rate in heart failure (33.4%) and ischemic heart disease (30.7%), before heart attack (16.9%) and stroke (33.8%). Consequently, the expected increase in coronary artery disease prevalence is set to stimulate the drug-coated balloon market.

How is the global drug-coated balloons market divided into key segments?

The drug-coated balloons market covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

Who are the key firms paving the way for growth in the drug-coated balloons market?

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

Which trends are expected to transform the drug-coated balloons market?

The trend of product innovations is becoming increasingly prevalent in the drug-coated balloon market. Major industry players in this market are concentrating on the development of novel technological and innovative solutions to consolidate their market presence. For example, in August 2022, Becton, Dickinson, and Company (BD), a medical technology firm based in the US, commenced the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB). The objective of this trial is to examine the safety and efficacy of the sirolimus DCB in managing peripheral artery disease, a health issue that substantially affects both mobility and the quality of life of patients.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10829

What regions are contributing significantly to the growth of the drug-coated balloons market?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Generic Musculoskeletal Disorders Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generic-musculoskeletal-disorders-drugs-global-market-report

Pain Management Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Drug-Coated Balloons Market Over the Coming Decade?

The market for drug-coated balloons has seen a rapid expansion in the last few years. The market value is projected to increase from $1.08 billion in 2024 to $1.24 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.4%. The significant growth witnessed in the historical phase can be linked to factors such as a rise in cardiovascular illness, growing demand for minimally invasive operations, the widespread occurrence of peripheral artery disease (pad), lower rates of restenosis, and advancements in interventional cardiology.

In the coming years, the market for drug-coated balloons is anticipated to experience a swift rise. It is projected to escalate to “$2.22 billion by 2029, with a compound annual growth rate (CAGR) of 15.6%. The projected growth during this period can be accredited to the surge in the aging population, expansion of indications and applications, focus on outpatient and ambulatory care, synergy with drug delivery innovations, and global health initiatives. The predominant trends for this forecast period encompass regulatory approvals for new formulations, a focus on reducing side effects, the emergence of bioresorbable coatings, market growth in emerging economies, and patient-centric approaches.

What External and Internal Drivers Are Contributing to the Growth of the drug-coated balloons Market’s Growth?

An increase in the incidence of coronary artery disease is predicted to stimulate the expansion of the drug-coated balloons market. Coronary artery disease (CAD) is a health issue characterized by the constriction or blockade of the coronary arteries, which supply blood to the heart muscle. This can lead to heart attacks. Drug-coated balloons are medical tools used in the treatment of CAD, releasing a medication into the artery during the procedure to avert restenosis, or a re-narrowing of the artery after angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 by a US-based organization predicted a rise in all four cardiovascular risk factors among the general U.S populace from 2025 to 2060. Diabetes is expected to record the highest percentage increase of 39.3%, followed by dyslipidemia increasing by 27.6%, hypertension by 25.1%, and obesity by 18.3%. The study also found heart failure (33.4%) and ischemic heart disease (30.7%) to have the largest projected rate increases, followed by heart attack (16.9%) and stroke (33.8%). As such, the increasing occurrence of coronary artery disease is predicted to fuel the growth of the drug-coated balloon market.

Get Your Free Sample of the Global Drug-Coated Balloons Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What Are the Major Players Making an Impact in the Drug-Coated Balloons Market’s Growth?

Major companies operating in the drug-coated balloons market include:

• Acotec Scientific AG_x000D_

• B. Braun Melsungen AG_x000D_

• Biosensors International Group Ltd_x000D_

• Medtronic Inc._x000D_

• Boston Scientific Corporation_x000D_

Which Upcoming Trends Are Set to Influence the Drug-Coated Balloons Market’s Path Forward?

One major trend gaining traction in the drug-coated balloon market is product innovation. Companies in this market are constantly working on developing groundbreaking and innovative technological solutions to solidify their industry presence. For example, Becton, Dickinson, and Company (BD), a medical technology firm based in the US, kicked off the PREVISION first-in-human trial in August 2022. This particular trial involves a peripheral sirolimus drug-coated balloon (DCB) and aims to evaluate its safety and efficacy in treating patients with peripheral artery disease, a condition that severely affects mobility and quality of life.

Get Instant Access to the Global Drug-Coated Balloons Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Which Segments of the Drug-Coated Balloons Market Hold the Most Potential for Future Development?

The drug-coated balloons market covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

What Regions Are Steering Growth in the Drug-Coated Balloons Sector?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Can We Define the Drug-Coated Balloons Market and Its Key Components?

A drug-coated balloon (DCB) is a medical device used in the treatment of narrowed or blocked blood vessels, primarily in the field of interventional cardiology and interventional radiology. It is designed to deliver medication directly to the site of vascular disease while simultaneously performing angioplasty.

Browse Through More Similar Reports By The Business Research Company:

Generic Musculoskeletal Disorders Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generic-musculoskeletal-disorders-drugs-global-market-report

Pain Management Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: